Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18321603rdf:typepubmed:Citationlld:pubmed
pubmed-article:18321603lifeskim:mentionsumls-concept:C0038734lld:lifeskim
pubmed-article:18321603lifeskim:mentionsumls-concept:C1883036lld:lifeskim
pubmed-article:18321603lifeskim:mentionsumls-concept:C1708096lld:lifeskim
pubmed-article:18321603lifeskim:mentionsumls-concept:C0150312lld:lifeskim
pubmed-article:18321603pubmed:issue3-4lld:pubmed
pubmed-article:18321603pubmed:dateCreated2008-4-8lld:pubmed
pubmed-article:18321603pubmed:abstractTextThe aim of the present work was to explore the use of heteroaromatic thiol compounds, namely derivatives of pyridine and pyrimidine, as redox reagents for the in vitro-refolding of a recombinantly expressed single-chain Fv fragment (scFvOx). The mixed disulfide of scFvOx with glutathione was used as a starting material, while reduced glutathione, 4-mercaptopyridine, 2-mercaptopyrimidine, 2-mercaptopyridine N-oxide, and the mercaptobenzene derivative thiosalicylic acid, respectively, served as catalysts for the formation of native disulfide bonds during renaturation. In contrast to thiosalicylic acid, and despite their significantly lower thiol pKa values, none of the heteroaromatic thiol compounds accelerated the apparent kinetics of in vitro-refolding compared to the naturally occurring peptide glutathione. However, significantly improved renaturation yields were observed in the presence of 4-mercaptopyridine and 2-mercaptopyrimidine, demonstrating the usefulness of aromatic thiol compounds as reagents for the in vitro-refolding of antibody fragments.lld:pubmed
pubmed-article:18321603pubmed:languageenglld:pubmed
pubmed-article:18321603pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18321603pubmed:citationSubsetIMlld:pubmed
pubmed-article:18321603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18321603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18321603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18321603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18321603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18321603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18321603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18321603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18321603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18321603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18321603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18321603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18321603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18321603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18321603pubmed:statusMEDLINElld:pubmed
pubmed-article:18321603pubmed:monthAprlld:pubmed
pubmed-article:18321603pubmed:issn0168-1656lld:pubmed
pubmed-article:18321603pubmed:authorpubmed-author:RudolphRainer...lld:pubmed
pubmed-article:18321603pubmed:authorpubmed-author:LangeChristia...lld:pubmed
pubmed-article:18321603pubmed:authorpubmed-author:PatilGaneshGlld:pubmed
pubmed-article:18321603pubmed:issnTypePrintlld:pubmed
pubmed-article:18321603pubmed:day30lld:pubmed
pubmed-article:18321603pubmed:volume134lld:pubmed
pubmed-article:18321603pubmed:ownerNLMlld:pubmed
pubmed-article:18321603pubmed:authorsCompleteYlld:pubmed
pubmed-article:18321603pubmed:pagination218-21lld:pubmed
pubmed-article:18321603pubmed:meshHeadingpubmed-meshheading:18321603...lld:pubmed
pubmed-article:18321603pubmed:meshHeadingpubmed-meshheading:18321603...lld:pubmed
pubmed-article:18321603pubmed:meshHeadingpubmed-meshheading:18321603...lld:pubmed
pubmed-article:18321603pubmed:meshHeadingpubmed-meshheading:18321603...lld:pubmed
pubmed-article:18321603pubmed:meshHeadingpubmed-meshheading:18321603...lld:pubmed
pubmed-article:18321603pubmed:meshHeadingpubmed-meshheading:18321603...lld:pubmed
pubmed-article:18321603pubmed:meshHeadingpubmed-meshheading:18321603...lld:pubmed
pubmed-article:18321603pubmed:meshHeadingpubmed-meshheading:18321603...lld:pubmed
pubmed-article:18321603pubmed:meshHeadingpubmed-meshheading:18321603...lld:pubmed
pubmed-article:18321603pubmed:meshHeadingpubmed-meshheading:18321603...lld:pubmed
pubmed-article:18321603pubmed:meshHeadingpubmed-meshheading:18321603...lld:pubmed
pubmed-article:18321603pubmed:meshHeadingpubmed-meshheading:18321603...lld:pubmed
pubmed-article:18321603pubmed:meshHeadingpubmed-meshheading:18321603...lld:pubmed
pubmed-article:18321603pubmed:meshHeadingpubmed-meshheading:18321603...lld:pubmed
pubmed-article:18321603pubmed:year2008lld:pubmed
pubmed-article:18321603pubmed:articleTitleIn vitro-refolding of a single-chain Fv fragment in the presence of heteroaromatic thiols.lld:pubmed
pubmed-article:18321603pubmed:affiliationInstitut für Biotechnologie, Martin-Luther-Universität Halle/Wittenberg, Kurt-Mothes-Str.3, 06120 Halle (Saale), Germany.lld:pubmed
pubmed-article:18321603pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18321603pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed